(PharmaNewsWire.Com, June 22, 2021 ) Smart syringes gaining popularity across the globe, due to their safety mechanisms. These syringes are equipped with various features to avoid needlestick injuries in a patient who uses smart syringes & avoid transmission of blood-borne diseases like hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). The increase in incidence of infections, due to unsafe injection practices, has increased substantially. For instance, as per the World Health Organization each year, about 2 Mn injuries from needle-sticks and other sharp objects occur to over 35 Mn health care workers in the world. Furthermore, growing need to prevent hospital acquired infections is expected to drive the market growth throughout the forecast period.
The increase in COVID-19 pandemic across the globe is expected to boost the demand for smart syringes over the forecast period. The increasing number of COVID-19 patients has created a shortage of PPE, face masks, and gowns. Thus, government and private organizations have started manufacturing of smart syringe.
Market Segmentation
Based on the product type, market is segmented into Auto-disable syringes, Active safety syringes, and Passive safety syringes. Based on the application, market is segmented into Vaccination, Blood Specimen Collection, and Drug delivery.
Based on the end user, market is segmented into Hospitals & HMOs, Family practices (Physicians), Diabetic patients, Psychiatrics and, Others.
Some key operating players are listed in this report such as Gerresheimer AG, Baxter, Terumo Corporation, B. Braun Melsungen AG, AdvaCare Pharma, Cardinal Health, Becton, Dickinson and Company, Parker Hannifin Corp, Numedico Technologies Pty Ltd, Retractable Technologies, Inc., etc.
Market Taxonomy
By Product Type • Auto-disable syringes • Active safety syringes • Passive safety syringes
By Application • Vaccination • Blood Specimen Collection • Drug delivery
By End User • Hospitals & HMOs • Family practices (Physicians) • Diabetic patients • Psychiatrics • Others
By Region • North America • Latin America • Europe • Asia Pacific • Middle East & Africa
Regional Analysis
The Global Smart-Syringes-Market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America region is anticipated to dominate the global smart syringes market. This is mainly attributed to growing incidences chronic diseases like diabetes, cardiovascular diseases, etc.in countries in the region. Also, APAC region is expected to be an emerging market for the global smart syringes market, and is anticipated to register highest CAGR in during the forecasted period. Due to the increase in demand for minimal invasive medical procedure & increasing healthcare expenditure in the region.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
